Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House Dems Settle On 2.9% Excise Tax On Device Sales Starting In 2013

This article was originally published in The Gray Sheet

Executive Summary

A 2.9% excise tax would be imposed on device manufacturers beginning in 2013 under a House reconciliation bill released by Democrats March 18

You may also be interested in...



Device Tax Will Present "Manageable" Challenges, Analysts Say

The final health care reform device industry tax provision, while presenting a challenge, will be manageable by the sector at large, according to industry analysts

Device Tax Will Present "Manageable" Challenges, Analysts Say

The final health care reform device industry tax provision, while presenting a challenge, will be manageable by the sector at large, according to industry analysts

Obama Budget Request Would Fund National Device Registry At FDA

The Obama administration's fiscal year 2011 budget request includes $4 million for a new medical device registry that would link unique device identifiers to electronic health data. The registry would be designed and built by FDA

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028640

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel